Drug of Abuse Testing with DETECTABUSE®
Toxicology QC Solutions – Providing labs with cutting edge products
Receive your quote directly from the manufacturer.
LGC Clinical Diagnostics is a leading manufacturer of controls for drugs of abuse and pregnancy testing. Our DETECTABUSE® Quality Controls have been an industry gold standard for urine drug of abuse testing since 1991. Designed to work on most available testing devices on the market, DETECTABUSE® quality control formulations are updated as the market changes and new testing devices become available. These new controls are DEA exempt but are not CE marked yet and are therefore not available for sales in EU countries.
Optimize quality control across the clinical lab
Every diagnosis and treatment decision depends on the reliability of clinical lab results, making quality control (QC) a critical component of success, from assay validation and improving operational efficiency to risk management, staff development and partnership building. Today’s labs must meet rising regulatory standards while managing leaner teams and tighter budgets. This SelectScience guide, produced in partnership with LGC Clinical Diagnostics, a supplier of liquid-ready quality controls for clinical chemistry, toxicology and pregnancy testing, urinalysis, and molecular diagnostics and serology assays, provides practical insights for lab directors and quality managers to build QC strategies that are not only compliant but also resilient and scalable.
Inside, you will find:
- A whitepaper on best practices for clinical lab QC
- An analysis of diagnostic errors and the lab’s role
- A comparison of informatics security options
- A curated selection of QC-supporting products
Whether you're refining your QC protocols or preparing for future challenges, this eBook delivers the knowledge and tools to help your clinical lab thrive.
Download it now to stay ahead and make quality control a strategic advantage in your lab.
